EFAGLANDIN
pharmaceutical preparations and substances for treatment in humans and animals of diabetes, mastalgia, skin disorders, premenstrual syndrome, cancer, inflammatory diseases, asthma, hypertension, peptic ulcer, schizophrenia, psychological depression, alzheimer's disease, viral infections, myalgic encephalitis (ME), radiation effects, and intestinal atrophy and for milk enhancement and the prevention of re-occlusions of arteries; dietary food supplements and infant's and invalid's foods
Cancelled · August 3, 1992 · 74300142 ·